Paper20008280
Reversible or irreversible remodeling in pulmonary arterial hypertension.
Sakao S and 2 others. Am J Respir Cell Mol Biol, 2010. Cited by 130 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Reversible or irreversible remodeling in pulmonary arterial hypertension. Papers, record 20008280. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20008280
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Airway Remodeling | Major topic |
| Hypertension, Pulmonary | Major topic |
| Pulmonary Artery | Major topic |
| Endothelial Cells | |
| Humans | |
| Models, Biological | |
| Myocytes, Smooth Muscle |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 5P01 HL66254-03 | NHLBI NIH HHS | United States | P01HL662540 | PubMed | NIH RePORTER |
| P01HL066254 | NIH | NIH RePORTER |
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3740659 | The case for treatment of selected patients with primary pulmonary hypertension. | Am Rev Respir Dis | 1986 | https://conductscience.org/library/papers/3740659 | PubMed |
| 2 | 2501548 | [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats]. | Nihon Kyobu Shikkan Gakkai Zasshi | 1989 | https://conductscience.org/library/papers/2501548 | PubMed |
| 3 | 15375007 | Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis. | Circ Res | 2004 | https://conductscience.org/library/papers/15375007 | PubMed |
| 4 | 7519783 | Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7519783 | PubMed |
| 5 | 19628780 | Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. | Am J Respir Crit Care Med | 2009 | https://conductscience.org/library/papers/19628780 | PubMed |
| 6 | 1603138 | An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. | N Engl J Med | 1992 | https://conductscience.org/library/papers/1603138 | PubMed |
| 7 | 16369926 | No role for kaposi sarcoma-associated herpesvirus in pediatric idiopathic pulmonary hypertension. | Pediatr Pulmonol | 2006 | https://conductscience.org/library/papers/16369926 | PubMed |
| 8 | 17586694 | Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. | Am J Physiol Lung Cell Mol Physiol | 2007 | https://conductscience.org/library/papers/17586694 | PubMed |
| 9 | 17227868 | Alterations of cellular bioenergetics in pulmonary artery endothelial cells. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17227868 | PubMed |
| 10 | 9198250 | Regulation of the tissue factor gene. | Thromb Haemost | 1997 | https://conductscience.org/library/papers/9198250 | PubMed |
| 11 | 8497283 | Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8497283 | PubMed |
| 12 | 15194171 | Proceedings of the 3rd World Symposium on Pulmonary Arterial Hypertension. Venice, Italy, June 23-25, 2003. | J Am Coll Cardiol | 2004 | https://conductscience.org/library/papers/15194171 | PubMed |
| 13 | 16847299 | Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. | Ann Intern Med | 2006 | https://conductscience.org/library/papers/16847299 | PubMed |
| 14 | 17222789 | A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. | Cancer Cell | 2007 | https://conductscience.org/library/papers/17222789 | PubMed |
| 15 | 8797416 | Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension. | Chest | 1996 | https://conductscience.org/library/papers/8797416 | PubMed |
| 16 | 17526595 | Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. | Am J Physiol Lung Cell Mol Physiol | 2007 | https://conductscience.org/library/papers/17526595 | PubMed |
| 17 | 11502704 | Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. | Circulation | 2001 | https://conductscience.org/library/papers/11502704 | PubMed |
| 18 | 12682495 | Effect of a surgical aortocaval fistula on monocrotaline-induced pulmonary hypertension. | Crit Care Med | 2003 | https://conductscience.org/library/papers/12682495 | PubMed |
| 19 | 7615796 | Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7615796 | PubMed |
| 20 | 11179130 | 40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats. | Am J Respir Crit Care Med | 2001 | https://conductscience.org/library/papers/11179130 | PubMed |
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 130 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41104021 | Patient-Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension. | Pulm Circ | 2025 | https://conductscience.org/library/papers/41104021 | PubMed |
| 40924716 | Comprehensive analysis of disulfidptosis-related genes in pulmonary hypertension through machine learning and immune infiltration: Spotlight on USP32 and ZNF655 as key regulators. | PLoS One | 2025 | https://conductscience.org/library/papers/40924716 | PubMed |
| 40579840 | The long-term outcome and changes in tricuspid regurgitation pressure gradient in dogs diagnosed with pulmonary hypertension and Angiostrongylus vasorum infestation. | J Small Anim Pract | 2025 | https://conductscience.org/library/papers/40579840 | PubMed |
| 38708342 | Phosphoproteomics analysis of serum from dogs affected with pulmonary hypertension secondary to degenerative mitral valve disease. | PeerJ | 2024 | https://conductscience.org/library/papers/38708342 | PubMed |
| 38596466 | Proteomic analysis of the serum in dogs with pulmonary hypertension secondary to myxomatous mitral valve disease: the preliminary study. | Front Vet Sci | 2024 | https://conductscience.org/library/papers/38596466 | PubMed |
| 38501963 | Pulmonary Vascular Dysfunctions in Cystic Fibrosis. | Physiology (Bethesda) | 2024 | https://conductscience.org/library/papers/38501963 | PubMed |
| 38347241 | Nupr1-mediated vascular smooth muscle cell phenotype transformation involved in methamphetamine induces pulmonary hypertension. | Cell Biol Toxicol | 2024 | https://conductscience.org/library/papers/38347241 | PubMed |
| 37881627 | Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37881627 | PubMed |
| 37268944 | HMGB1-induced activation of ER stress contributes to pulmonary artery hypertension in vitro and in vivo. | Respir Res | 2023 | https://conductscience.org/library/papers/37268944 | PubMed |
| 37060716 | A multi-scale computational model for the passive mechanical behavior of right ventricular myocardium. | J Mech Behav Biomed Mater | 2023 | https://conductscience.org/library/papers/37060716 | PubMed |
| 37035669 | Pericytes: The lung-forgotten cell type. | Front Physiol | 2023 | https://conductscience.org/library/papers/37035669 | PubMed |
| 36923571 | AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study. | ERJ Open Res | 2023 | https://conductscience.org/library/papers/36923571 | PubMed |
| 36670936 | Specificity Protein 1-Mediated Promotion of CXCL12 Advances Endothelial Cell Metabolism and Proliferation in Pulmonary Hypertension. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/36670936 | PubMed |
| 35936724 | Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention. | Front Oncol | 2022 | https://conductscience.org/library/papers/35936724 | PubMed |
| 35838373 | Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide. | Curr Opin Pulm Med | 2022 | https://conductscience.org/library/papers/35838373 | PubMed |
| 35582418 | Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways. | Int J Med Sci | 2022 | https://conductscience.org/library/papers/35582418 | PubMed |
| 35298304 | Endothelial Senescence: A New Age in Pulmonary Hypertension. | Circ Res | 2022 | https://conductscience.org/library/papers/35298304 | PubMed |
| 35033157 | Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension. | Chin Med | 2022 | https://conductscience.org/library/papers/35033157 | PubMed |
| 35011628 | The Isoquinoline-Sulfonamide Compound H-1337 Attenuates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Rats. | Cells | 2021 | https://conductscience.org/library/papers/35011628 | PubMed |
| 34966541 | Phosphoproteomic analysis of lung tissue from patients with pulmonary arterial hypertension. | Pulm Circ | 2021 | https://conductscience.org/library/papers/34966541 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TXK | 7294 | PubTator's text mining | https://conductscience.org/library/genes/7294 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20008280
GET https://conductscience.org/api/papers/v1/20008280/references?page=2